MASTERCARD
14.3.2023 18:29:40 CET | Business Wire | Press release
Bringing together the journeys of some of the world’s most inspiring female leaders in arts, sports, politics, hospitality, financial services and beyond, Mastercard has unveiled a coffee-table book, ‘Lasting Legacy - Honoring 25 Visionaries to Celebrate 25 Years of Priceless’. Launched during Women’s Month 2023, the book marks the 25th anniversary of Mastercard’s renowned Priceless platform, which has been connecting people to their passions for a quarter of a century.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230314005890/en/
Mastercard Lasting Legacy Book (Photo: AETOSWire)
Mastercard is committed to creating a more equitable world for all and this project marks the company’s latest milestone in unlocking opportunities and celebrating the role of women in society. By exploring the role of these trailblazers, the book aims to inspire readers to take action in their own lives and communities to close the gender gap and create a more inclusive future.
The legacy piece highlights the journeys and impact of women including Her Excellency Dr. Aisha Bint Butti Bin Bishr, Global Digital Magnate, Vice Chairwoman of Emaar Development Board & Former Founding Director General of Smart Dubai; Nona Gaprindashvili, Chess Legend; Dr. Maya Morsy, President, Egypt's National Council for Women; Raha Moharrak, Adventurer; Sarah Baydoun, Founder and Creative Director of Sarah’s Bag; Jessica Kahawaty, Philanthropist, Entrepreneur and Model; Laila Mostafa Abdullatif, Director General of Emirates Nature-WWF; Valeriya Ionan, Deputy Minister for Eurointegration at the Ministry of Digital Transformation of Ukraine, and Naoko Yamazaki, Astronaut & Engineer, among others.
“This book has been a true labor of love for us, and a testament to the women who are driving progress and uplifting communities around the world. It is our hope that the stories in ‘Lasting Legacy’ will encourage readers, regardless of their gender, to pursue their passions and make a positive impact on society, to inspire generations to come,” said Beatrice Cornacchia, Senior Vice President, Marketing and Communications, Eastern Europe, Middle East and Africa, Mastercard.
‘Lasting Legacy - Honoring 25 Visionaries to Celebrate 25 Years of Priceless’ represents the evolution of Mastercard's Priceless platform, which has progressed to reflect the company’s ongoing transformation and the changing world of consumers.
For more information on the book’s availability and to read the full interviews, visit here.
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230314005890/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corient Accelerates European Growth With the Addition of Letus Private Office30.6.2026 07:15:00 CEST | Press release
Leading French multi-family office with approximately US$5 billion in assets is Corient’s fourth European acquisition, growing firm’s global assets to approximately US$523 billion Corient today announced an agreement to acquire Letus Private Office (“Letus”), an independent multi-family office and wealth advisory firm serving entrepreneurs, founders and other ultra-high-net-worth individuals and families across France and Europe. The acquisition, subject to closing, builds on recent transactions that have made Corient the world’s largest multi-family office and non-bank wealth manager focused on ultra-high-net worth and high-net-worth clients. Paris-based Letus was founded in 2016 and is led by Managing Partners Anice Chlagou, Stephen Lasry and Alexandre Tsouli, and Partner Sacha Levy. It manages and administers approximately €4.1 billion (about US$5 billion). Letus serves ultra-high-net worth clients, primarily entrepreneurs and their families, providing comprehensive, bespoke service
“BOCCHI THE ROCK!” SeisyunComplex Premiered on June 20!30.6.2026 07:00:00 CEST | Press release
A New Work for “TOKYO Night & Light” — Surpassing 1.4 Million Total Visitors The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260625185578/en/ We are pleased to announce that the first screening of “BOCCHI THE ROCK!” SeisyunComplex, a new projection mapping work inspired by the highly popular anime “BOCCHI THE ROCK!”, was held on Saturday, June 20. Following its premiere, the work will be screened throughout the year as part of the weekday and weekend lineup of “TOKYO Night & Light”. Since its launch in February 2024, “TOKYO Night & Light” has welcomed visitors from Japan and around the world, with total attendance surpassing 1.4 million. As on
Hengrui’s Heng Yi® Approved in China as an Innovative Cyclosporine Ophthalmic Solution for the Treatment of Dry Eye Disease30.6.2026 07:00:00 CEST | Press release
Hengrui Pharma, a global pharmaceutical company focused on scientific and technological innovation, and Novaliq GmbH (“Novaliq”), a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on its unique EyeSol® water-free platform technology, announce today that on June 23, 2026, the China National Medical Products Administration (NMPA) has approved Heng Yi® (0.1% cyclosporine ophthalmic solution) for the treatment of patients with dry eye disease, aiming to increase tear secretion in patients with reduced tear production and improve the sign of the disease. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629052295/en/ Heng Yi Heng Yi® is the first and only water-free 0.1% cyclosporine ophthalmic solution and the second dry eye disease drug product approved in China based on the EyeSol® platform technology, following the approval of Heng Qin® (perfluorohexyloctane ophthalmic solution) in 202
Nebex Raises $30M Seed Round Led by GV to Build Market Infrastructure for the Global Space Economy29.6.2026 17:38:00 CEST | Press release
The new funding and banking relationship allow Nebex to scale the market and unlock the commercial space economy. Nebex, the market infrastructure platform for the global space economy, announced a $30M seed investment led by GV (Google Ventures), with participation from other top-tier venture funds. The company also announced a banking relationship with J.P. Morgan. The capital raise and new banking relationship will help Nebex scale its platform and connect sovereign space programs with the founders and companies building new technologies to serve the space industry. "We built Nebex because we've seen firsthand that ambitious space founders struggle to deliver complex sovereign programs due to the lack of capital markets infrastructure that supports revenue and cashflow. This is something that exists in nearly every other industry," said Tejpaul Bhatia, CEO of Nebex. "Support from these organizations gives Nebex the additional leverage and financial infrastructure to build the global
Medisca Enters Its Next Chapter Under Founder Antonio Dos Santos29.6.2026 16:19:00 CEST | Press release
Medisca today announced that Founder and Chairman Antonio Dos Santos has returned to the role of Chief Executive Officer as the company enters its next chapter of growth. For more than 35 years, Dos Santos has helped shape Medisca into a global leader in pharmaceutical compounding. As Chief Executive Officer, he will lead the company's long-term strategy, with a focus on expanding Medisca's global reach, investing in new areas of growth, strengthening strategic partnerships, and continuing to advance the products, services, education, and expertise that healthcare professionals rely on every day. "When I founded Medisca, my vision was to raise the standard of pharmaceutical compounding by bringing pharmaceutical-grade quality to the industry and giving healthcare professionals access to the products, knowledge, and innovation they needed to deliver better patient care," said Antonio Dos Santos, Founder and Chief Executive Officer of Medisca. "That purpose continues to guide us. As we b
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom